Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus

By Aliya A. Khan, A. Morrison, D. Hanley, D. Felsenberg, Laurie K McCauley, F. O'ryan, I. Reid, S. Ruggiero, A. Taguchi, S. Tetradis and 24 more. Journal of Bone and Mineral Research, 2015

1,288 citations recorded by the source corpus.

Subfields: Oncology, Orthopedics and Sports Medicine, Rheumatology

View Paper: https://www.semanticscholar.org/paper/680e8e0e3f798981a50654ac4d65b0faf29ccaf4

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

1. Eugene V. McCloskey
2. Chris Cooper
3. J. Kanis

In Orthopedics and Sports Medicine

1. Chris Cooper
2. Eugene V. McCloskey
3. J. Kanis
4. Nicholas C. Harvey
5. H. Johansson
6. J. Reginster
7. R. Rizzoli
8. on behalf of the International Osteoporosis Foundation

Citations in the corpus

• UK clinical guideline for the prevention and treatment of osteoporosis (2017, background): “Risk factors for osteonecrosis of the jaw include poor oral hygiene, dental disease, dental interventions, cancer, chemotherapy or glucocorticoid therapy [115].”
• The clinician’s guide to prevention and treatment of osteoporosis (2022, background): “The magnitude of risk reduction associated with discontinuing antiresorptive therapy even in those with ONJ is not known but must be weighed against known negative outcomes of low bone density and fractures [207, 209, 210].”